Sector

With a promising rate of growth, outsourcing partners of the future are rising to the challenge of a transforming industry

It’s time for the U.S. to sift through domestic drug manufacturing efforts

Key takeaways from the Association for Accessible Medicines’ Access! 2024 meeting

The Indiana-based CDMO is redefining injectable drug manufacturing with community collaboration and technology

The San Francisco-based IDMO says its differentiated technology will allow pharma companies to unlock massive productivity gains in cell therapy — and save the lives of millions...

With a dual mission to serve both patients and the planet, the Switzerland-based CDMO takes on today’s most complex sterile medicines

Four young companies built with intention tackle the future of medicine

Though excipients are a necessary drug component that can often be taken for granted, the ever-changing pharma landscape is always pushing us to shift our perspectives.

Modern-day medications might finally mean obesity can be viewed as treatable

Companies prioritizing optimized synthetic routes, stable API forms, and verified analytical tools set the stage for phase I clinical manufacturing success